1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
Role of FLT3 in Acute Myeloid Leukemia: Molecular mechanisms and Therapeutic opportunities
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Mechanisms of therapy resistance in acute lymphoblastic leukemia
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
The role of SRC family kinases in FLT3 signaling
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Direct role of FLT3 in regulation of early lymphoid progenitors
(
- Contribution to journal › Article
-
Mark
Translational studies on acute myeloid leukemia focus on the receptor tyrosine kinase FLT3
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
(
- Contribution to journal › Article
- 2017
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
(
- Contribution to journal › Article
- 2015
-
Mark
Murine germinal center B cells require functional fms-like tyrosine kinase 3 signaling for IgG1 class-switch recombination
2015) In Proceedings of the National Academy of Sciences of the United States of America 112(48). p.6644-6653(
- Contribution to journal › Article
- 2014
-
Mark
SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
(
- Contribution to journal › Scientific review